Paris-Dakner Microspherules Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 8.10 M
as on 05-12-2024
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 4.50 Cr
as on 05-12-2024
- Satisfied Charges ₹ 5.28 Cr
as on 05-12-2024
About Paris-Dakner Microspherules
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.10 M.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹5.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mohanasundram Madhumathi, Subramania Mohanasundaram, and Mohanasundaram Umarani serve as directors at the Company.
- CIN/LLPIN
U74910TN1998PTC039823
- Company No.
039823
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1998
- Date of AGM
29 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Paris-Dakner Microspherules?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramania Mohanasundaram  | Managing Director | 01-Apr-2005 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohanasundram Madhumathi | Additional Director | 07-Sep-2009 | Current |
| Mohanasundaram Umarani | Director | 12-Jun-2006 | Current |
Financial Performance of Paris-Dakner Microspherules.
Enhance accessibility to Paris-Dakner Microspherules's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Paris-Dakner Microspherules?
Unlock access to Paris-Dakner Microspherules's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Paris-Dakner Nanolifesciences Private LimitedActive 15 years 4 monthsMohanasundram Madhumathi and Mohanasundaram Umarani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
International Asset Reconstruction Company Private Limited Creation Date: 30 Mar 2010 | ₹4.50 Cr | Open |
Karnataka Bank Limited Creation Date: 04 Jan 1999 | ₹5.01 Cr | Satisfied |
Karnataka Bank Limited Creation Date: 04 Jan 1999 | ₹2.70 M | Satisfied |
How Many Employees Work at Paris-Dakner Microspherules?
Unlock and access historical data on people associated with Paris-Dakner Microspherules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paris-Dakner Microspherules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paris-Dakner Microspherules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
